CytoDyn Inc.
CYDYOTCCIK 1175680HealthcareFiscal year ends May 31
Reports and events: 447 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1920:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001175680-26-000038 |
| 2026-10-1412:33 ET | 10-Q | Quarterly reportPeriod 2026-08-31 | 0001175680-26-000035 |
| 2026-09-2820:48 ET | DEF 14A | Proxy statementPeriod 2026-09-28 | 0001175680-26-000026 |
| 2026-08-3112:31 ET | 10-K | Annual reportPeriod 2026-05-31 | 0001175680-26-000014 |
| 2026-04-3020:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001175680-26-000002 |
| 2026-04-2221:21 ET | S-1 | Registration statement | 0001104659-26-046921 |
| 2026-04-0812:30 ET | 10-Q | Quarterly reportPeriod 2026-02-28 | 0001104659-26-040687 |
| 2026-03-2421:15 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-26-033943 |
| 2026-03-0513:35 ET | 8-K | 3.02 Unregistered sale of equity | 0001104659-26-023856 |
| 2026-01-0913:30 ET | 10-Q | Quarterly reportPeriod 2025-11-30 | 0001104659-26-002335 |
| 2025-12-0113:40 ET | 8-K | 8.01 Other events | 0001104659-25-117154 |
| 2025-11-2122:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-115056 |
| 2025-11-0313:38 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-105306 |
| 2025-10-1012:30 ET | 10-Q | Quarterly reportPeriod 2025-08-31 | 0001104659-25-098552 |
| 2025-09-2920:30 ET | DEF 14A | Proxy statementPeriod 2025-11-21 | 0001104659-25-094518 |
| 2025-07-2520:34 ET | 10-K | Annual reportPeriod 2025-05-31 | 0001558370-25-009617 |
| 2025-05-1621:15 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001558370-25-007954 |
| 2025-05-0621:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-006531 |
| 2025-04-1421:15 ET | 10-Q | Quarterly reportPeriod 2025-02-28 | 0001558370-25-004774 |
| 2025-01-1422:15 ET | 10-Q | Quarterly reportPeriod 2024-11-30 | 0001558370-25-000207 |
| 2024-11-2222:15 ET | 8-K | 5.07 Shareholder vote results | 0001558370-24-015918 |
| 2024-10-1521:16 ET | 10-Q | Quarterly reportPeriod 2024-08-31 | 0001558370-24-013320 |
| 2024-10-1113:00 ET | DEF 14A | Proxy statementPeriod 2024-11-22 | 0001558370-24-013250 |
| 2024-09-3021:01 ET | 10-K/A | Annual report, amendedPeriod 2024-05-31 | 0001558370-24-013091 |
| 2024-09-0900:42 ET | S-1 | Registration statement | 0001558370-24-012660 |
| 2024-08-1521:21 ET | 10-K | Annual reportPeriod 2024-05-31 | 0001558370-24-012328 |
| 2024-07-0912:46 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-009701 |
| 2024-06-2821:00 ET | 8-K | 4.01 Change of auditor | 0001558370-24-009629 |
| 2024-06-0321:15 ET | 8-K | 3.02 Unregistered sale of equity | 0001558370-24-008869 |
| 2024-05-0621:09 ET | 8-K | 4.01 Change of auditor | 0001558370-24-006814 |
| 2024-04-1521:18 ET | 10-Q | Quarterly reportPeriod 2024-02-29 | 0001558370-24-005134 |
| 2024-04-0812:31 ET | 8-K | 1.02 Termination of a material agreement | 0001558370-24-004802 |
| 2024-03-2821:16 ET | 8-K | 3.02 Unregistered sale of equity | 0001558370-24-004282 |
| 2024-02-0702:32 ET | S-1 | Registration statement | 0001558370-24-000836 |
| 2024-01-2913:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-000603 |
| 2024-01-1622:16 ET | 10-Q | Quarterly reportPeriod 2023-11-30 | 0001558370-24-000305 |
| 2023-12-2222:15 ET | 8-K | 8.01 Other events | 0001558370-23-020003 |
| 2023-12-1422:22 ET | 8-K | 8.01 Other events | 0001558370-23-019804 |
| 2023-11-2822:10 ET | 8-K | 1.02 Termination of a material agreement | 0001558370-23-019363 |
| 2023-11-2122:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-019285 |
| 2023-11-0920:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-23-018526 |
| 2023-11-0621:41 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-017624 |
| 2023-10-2321:16 ET | 10-Q | Quarterly reportPeriod 2023-08-31 | 0001558370-23-016632 |
| 2023-10-1021:15 ET | 8-K | 4.01 Change of auditor | 0001558370-23-016328 |
| 2023-09-2521:19 ET | DEF 14A | Proxy statementPeriod 2023-11-09 | 0001558370-23-016016 |
| 2023-09-2521:10 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001558370-23-016013 |
| 2023-09-1421:34 ET | 10-K | Annual reportPeriod 2023-05-31 | 0001558370-23-015718 |
| 2023-08-1721:15 ET | 8-K | 3.02 Unregistered sale of equity | 0001558370-23-015074 |
| 2023-07-1120:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-011799 |
| 2023-06-2121:17 ET | S-1 | Registration statement | 0001104659-23-073406 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:53 ET. Listed shows no prices and gives no investment advice.